0Q15.IL - Abbott Laboratories

IOB - IOB Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 176.83B
Enterprise value 184.20B
Trailing P/E 31.00
Forward P/E 23.20
PEG ratio (5-yr expected) 10.54
Price/sales (ttm)4.32
Price/book (mrq)4.79
Enterprise value/revenue 4.44
Enterprise value/EBITDA 17.02

Trading information

Stock price history

Beta (5Y monthly) 0.66
52-week change 3-4.55%
S&P500 52-week change 314.65%
52-week high 3115.37
52-week low 393.36
50-day moving average 3106.13
200-day moving average 3104.89

Share statistics

Avg vol (3-month) 337.95k
Avg vol (10-day) 327.85k
Shares outstanding 51.74B
Implied shares outstanding 6N/A
Float 81.73B
% held by insiders 10.55%
% held by institutions 176.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.04
Forward annual dividend yield 42.00%
Trailing annual dividend rate 31.96
Trailing annual dividend yield 31.95%
5-year average dividend yield 41.54
Payout ratio 458.36%
Dividend date 3N/A
Ex-dividend date 413 Apr 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 13.98%
Operating margin (ttm)18.00%

Management effectiveness

Return on assets (ttm)6.32%
Return on equity (ttm)15.93%

Income statement

Revenue (ttm)41.51B
Revenue per share (ttm)23.75
Quarterly revenue growth (yoy)-18.10%
Gross profit (ttm)24.58B
Net income avi to common (ttm)5.78B
Diluted EPS (ttm)3.25
Quarterly earnings growth (yoy)-46.10%

Balance sheet

Total cash (mrq)9.53B
Total cash per share (mrq)5.48
Total debt (mrq)17.03B
Total debt/equity (mrq)45.73
Current ratio (mrq)1.68
Book value per share (mrq)21.28

Cash flow statement

Operating cash flow (ttm)8.66B
Levered free cash flow (ttm)6.41B